Genetic Technologies
GENE
#10592
Rank
A$5.25 M
Marketcap
A$1.08
Share price
0.00%
Change (1 day)
-72.01%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of A-$0.04711 a decrease over its 2022 EPS that were of A-$0.03127.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023A-$0.0471150.65%
2022A-$0.03127-99.04%
2021A-$3.25-46.67%
2020A-$6.09-99.38%
2019A-$974.7810809.09%
2018A-$8.94-41.07%
2017A-$15.16-18.37%
2016A-$18.57-40.24%
2015A-$31.08-53.41%
2014A-$66.72-10.66%
2013A-$74.6871.3%
2012A-$43.59-622.73%
2011A$8.34-108.8%
2010A-$94.77-3.92%
2009A-$98.6473.47%
2008A-$56.8624.96%
2007A-$45.50-10.93%
2006A-$51.09-48.62%
2005A-$99.43-8.31%
2004A-$108.44
2003N/A-100%
2002A-$67.33-9.36%
2001A-$74.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.18N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$12.57N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$7.18N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.92N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A-$0.43N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
A-$3.93N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.13N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$108.69N/A๐Ÿ‡บ๐Ÿ‡ธ USA